RxDoctor Payments Data

Joshua Atiyeh, PA

Physician Assistant · Pahrump, NVNPI 1386042182

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,286 of the $7,029 with a category attached, or 89.4%. It is spread thinly across 54 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,455, more than ten times the $143 reported in 2021. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,029in general payments, 2019–2025

Across 281 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$798
  • Daiichi Sankyo Inc.$566
  • AstraZeneca$525
  • Sobi, Inc$404
  • Inari Medical, Inc.$331
  • Fennec Pharmaceuticals, Inc.$301
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$6,28689%
  • Education$74311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,029 in reported general payments places this provider in the 90th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$1,374,096
Medicare patients
357
Services billed
53,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib11$174,299
XtandiEnzalutamide12$143,207
EliquisApixaban14$5,934
Letrozole120$1,847
Prochlorperazine Maleate61$1,219
Ondansetron OdtOndansetron26$1,007
Hydroxyurea59$934
Exemestane12$792
Tamoxifen Citrate35$545
Dexamethasone21$545
Anastrozole61$516
Morphine Sulfate13$445
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$300
Ondansetron Hcl13$260
Gabapentin22$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi$239$143,20712 claims
PfizerEliquis$184$5,93414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Pahrump

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →